PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 498.00
+6.00 (1.22%)
Oct 31, 2025, 2:38 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 184.18 billion as of October 31, 2025. Its market cap has decreased by -13.12% in one year.
Market Cap
184.18B
Enterprise Value
164.34B
Revenue
12.63B
Ranking
n/a
PE Ratio
45.60
Stock Price
498.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 184.18B, an increase of 367.64%. That is a compound annual growth rate of 14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 184.18B | -10.04% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | 24.71B | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lotus Pharmaceutical | 75.87B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.27B |
| Polaris Group | 27.16B |
| Pegavision | 25.74B |
| Center Laboratories | 25.23B |